Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach (GLUCOPULSE) (GLUCOPULSE)

May 16, 2022 updated by: University Hospital, Montpellier

Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach

Eating Disorders (ED) are a major public health problem. Current care remains only partially effective and the pathophysiology of the disorders remains to be deepened. With regard to compulsive ED (bulimia and binge eating disorder), our clinical experience suggests that one of the major triggers for crisis may be related to glycemia. In fact, bulimia could be considered as a vicious circle where the binge eating disorder is going to be followed by a food restriction in order to control weight , putting the subject in a situation of "energy deficiency" which will favor the emergence of new crises . Technological advances have resulted in the emergence of new measuring devices, such as "tracking", which records continuous glycemia, which would allow us to explore these clinical hypotheses.

Study Overview

Detailed Description

This is an open-label, exploratory, proof-of-concept study.

20 patients will be recruited from the day hospital of the Endocrinology and Nutrition Department of the University Hospital of Montpellier, Lapeyronie and from Emergencies and Post-psychiatric Emergencies Department.

During the inclusion visit, the dietician will explain to the patient the use of the dietary book and the glycemic sensor which will be allocated to it. The patient will also answer to self-questionnaires about his eating behavior.

No nutritional approach will be addressed so as not to alter the patient's eating behavior and not to influence the results.

They will be followed-up during 14 days.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Montpellier, France, 34 295
        • Recruiting
        • University Hospital
        • Principal Investigator:
          • Sylvain THIEBAUT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject suffering from eating disorders with at least 3 episodes of bulimia per week for at least 2 months
  • Subject affiliated to a health insurance or beneficiary of such a plan
  • Subject able to understand the nature, purpose and methodology of the study
  • Subject signed informed consent

Exclusion Criteria:

  • Subject suffering from eating disorders such as anorexia nervosa
  • Subject unable according to the investigator's opinion to keep updated a dietary book or to perform correctly the glycemic recordings
  • Subject suffering from somatic pathology (ex: diabetes) or psychiatric pathology assessed by the MINI (ex : severe current major depressive episode) that may interfere with the protocol according to the the investigator
  • Major subject legally protected (guardians or curators) or deprived of freedom by judicial or administrative order
  • Pregnant or nursing woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients
A dietary book will be given to the patient and will be filled by this one during 14 days
A glycemic sensor will be placed at the back of the patient's arm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of episodes of bulimia (measured from the dietary book) according to the interstitial glucose levels
Time Frame: At the return of the dietary book (14 days after enrollment)
Each information entered on the dietary book will be positioned on a chronological axis allowing to identify precisely when the eating disorder occurred
At the return of the dietary book (14 days after enrollment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Levels of impulse to make a crisis and food obsession and hunger depending on interstitial glucose levels
Time Frame: At the return of the dietary book (14 days after enrollment)
Each information entered on the dietary book will be positioned on a chronological axis allowing to identify precisely when the eating disorder occurred
At the return of the dietary book (14 days after enrollment)
Dietary patterns
Time Frame: At enrollment
Measured by the Emotional Appetite Questionnaire (EMAQ), 1 represent a food intake much smaller than usual ; 9 represent a food intake more significant than usual ; 5 represent a food intake as usual
At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2020

Primary Completion (Anticipated)

January 15, 2023

Study Completion (Anticipated)

July 1, 2023

Study Registration Dates

First Submitted

December 23, 2019

First Submitted That Met QC Criteria

December 23, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

May 17, 2022

Last Update Submitted That Met QC Criteria

May 16, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bulimia

Clinical Trials on Eating Behavior

3
Subscribe